- This event has passed.
Webinar: Towards a polio free world, the importance and GAP III requisites of (pre)clinical analyses models
October 15, 2020 @ 9:00 am - 10:00 am UTC+0
This webinar looks at the challenges surrounding (pre)clinical diagnostics and highlights the main GAP III regulatory directives and policies applicable to a polio essential facility.
This webinar is hosted by the Developing Countries Vaccine Manufacturers Network and Viroclinics-DDL. Please join us to learn from our experts about their experiences, operational insights and best practices. Our goal is to ultimately contribute to a polio free world. We will focus on the following topics:
- Improved analytical methods and assays in a polio essential facility, including: Virus titration / Qualification, Quantitative virus detection, Preclinical efficacy testing, Virus neutralization, Neurovirulence testing, Mutational analysis, Deep Sequencing;
- Key learnings in relation to the guidelines of the WHO Global Action Plan to minimize poliovirus facility-associated risk;
- The importance and added value of supporting processes, including logistical services, storage of viral samples, and more.
Marta Murreddu, PhD
Marta holds a PhD in General and Clinical Microbiology from the Universita Cattolica, Roma (Italy). After working as a Postdoc for nine years in the USA at the Virginia Tech specializing in Arbovirus research and in Georgetown University specializing in HBV, she joined Viroclinics. She has led several projects and has extensive experience in virology both in vitro and in vivo. She currently is a Study Director at Viroclinics-DDL.
Björn Koel, PhD
Björn graduated with a master’s degree focused on Infection and Immunity from Utrecht University and holds a PhD in virology from Erasmus MC, The Netherlands. He has led several interdisciplinary projects and has experience in wet-lab virology as well as bioinformatics. He currently is Study Director at Viroclinics Xplore.
Jeroen Strating, PhD
Jeroen holds a PhD in Cell Biology from Radboud University (The Netherlands). After his PhD, Jeroen studied cellular membranes and how enteroviruses usurp them for 11 years. He joined Viroclinics-DDL in 2019 as manager of molecular assay development (sequencing & RT-PCR). Since June 2020 Jeroen heads the department Molecular Virology Services.
Ivo Ploemen, Consultant Business Development
Ivo holds a PhD in Medical Microbiology from the Radboud University and an executive MBA from Tias School for Business and Society. He held various managerial positions at the institute for translational vaccinology (Intravacc) before joining Viroclinics in mid 2019 as a strategic consultant working with the Business Development team.
The webinar takes place on Thursday October 15th at 9:00 am CET. Registration is free, and the duration is 1 hour, including a Q&A session. Please register online HERE
For questions, please do not hesitate to contact us via: email@example.com.
To learn more about the Developing Countries Vaccine Manufacturers Network, please visit: www.dcvmn.org
Download our Viroclinics Xplore Factsheet Here
Here you will find our dedicated Polio Fact Sheet